Research Articles | Page 12 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances Myelodysplastic Syndromes (MDS)
Guideline-based indicators for adult patients with myelodysplastic syndromes Aug 2020 Blood Advances Myelodysplastic Syndromes (MDS)
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Nov 2020 Blood Advances Myelodysplastic Syndromes (MDS)
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome Apr 2023 Blood Cancer Myelodysplastic Syndromes (MDS)
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria Mar 2021 Blood cells, molecules and diseases Paroxysmal Nocturnal Hemoglobinuria (PNH)
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes Apr 2019 Blood Reviews Myelodysplastic Syndromes (MDS)
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review Jul 2023 Blood Reviews Myelodysplastic Syndromes (MDS)
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria Jul 2023 Blood Reviews Paroxysmal Nocturnal Hemoglobinuria (PNH)
Current and emerging strategies for management of myelodysplastic syndromes Dec 2020 Blood reviews Myelodysplastic Syndromes (MDS)